Company Overview of PureTech Ventures
Puretech Ventures is a venture capital and private equity firm specializing in pre-seed, seed, early stage, and bridge financing. The firm seeks to invest in life sciences companies with a focus on novel therapeutics, medical devices, pharmaceuticals, immunology, metabolism, consumer and digital, neuroscience, drug delivery, and research and platform technologies. Puretech Ventures was founded in 2001 and is based in Boston, Massachusetts.
500 Boylston Street
Boston, MA 02116
Founded in 2001
Key Executives for PureTech Ventures
Founder, Chief Executive Officer, Managing Partner, and Director
Co-Founder, Senior Partner Emeritus, and Director
Co-Founder, Senior Partner, and Director
Co-Founder and Senior Advisor
Manager of Finance and Operations
Compensation as of Fiscal Year 2014.
PureTech Ventures Key Developments
PureTech Announces Closing of $55 Million Growth Stage Investment Round; Announces Appointment of Three New Senior Partners
Oct 20 14
PureTech announced the closing of a $55 million growth stage investment round, with participation from Invesco Perpetual, a $120 billion group of funds. The funding will be used to drive its existing pipeline forward and to advance new healthcare related products and technologies.
In conjunction with the funding round, the company announced the appointment of three new senior partners: Dr. H Robert Horvitz, Nobel Laureate, David H. Koch Professor at MIT, and Investigator, Howard Hughes Medical Institute; Mr. Joi Ito, director of the MIT Media Lab and board member of Sony, the MacArthur Foundation, The New York Times, the Knight Foundation and Mozilla; and Dr. Raju Kucherlapati, Paul C. Cabot Professor in the Harvard Medical School Department of Genetics, co-founder of Millennium Pharmaceuticals & Abgenix, and Member of President Obama's Commission for the Study of Bioethical Issues. The new senior partners will join its existing senior partners and board members, Dr. Robert Langer, PureTech Co-founder & David H. Koch Institute Professor at MIT, Dr. Ben Shapiro, PureTech Chairman, former EVP of Worldwide Basic & External Research at Merck, Dr. John LaMattina, the company’s senior partner and former president of R & D at Pfizer Global Research and Development, and Daphne Zohar, the company’s Founder & CEO, recognized as a healthcare innovator and leader by the Boston Globe, MIT's Technology Review, Fierce Biotech and BioWorld.
PureTech Presents at Life Sciences Summit 2013, Nov-21-2013 02:15 PM
Nov 2 13
PureTech Presents at Life Sciences Summit 2013, Nov-21-2013 02:15 PM. Venue: Convene - Midtown East, 730 Third Avenue (Between East 45th and 46th Streets), 17th Floor, New York, NY 10017, United States. Speakers: Eric Elenko, Partner.
PureTech Ventures Presents at BioPharm America 2013, Sep-17-2013 through Sep-19-2013
Sep 17 13
PureTech Ventures Presents at BioPharm America 2013, Sep-17-2013 through Sep-19-2013. Venue: Westin Boston Waterfront Hotel, Boston, Massachusetts, United States. Presentation Date & Speakers: Sep-17-2013, Daphne Zohar, Founder, Managing Partner, and Director. Sep-18-2013, Daphne Zohar, Founder, Managing Partner, and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
January 9, 2015
October 20, 2014
May 16, 2014